THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 36 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $0 | – | 835 | +9.6% | 0.00% | – |
| Q1 2017 | $0 | – | 762 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 762 | -7.6% | 0.00% | – |
| Q3 2016 | $1,000 | – | 825 | +1733.3% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 45 | -100.0% | 0.00% | -100.0% |
| Q3 2015 | $1,797,000 | +84.3% | 441,385 | +82.8% | 0.00% | 0.0% |
| Q2 2015 | $975,000 | -1.4% | 241,449 | -0.9% | 0.00% | 0.0% |
| Q1 2015 | $989,000 | +21.9% | 243,596 | -4.4% | 0.00% | 0.0% |
| Q4 2014 | $811,000 | -38.6% | 254,905 | -30.3% | 0.00% | 0.0% |
| Q3 2014 | $1,320,000 | -21.1% | 365,528 | -13.5% | 0.00% | 0.0% |
| Q2 2014 | $1,672,000 | -21.6% | 422,334 | -5.7% | 0.00% | -50.0% |
| Q1 2014 | $2,132,000 | -7.9% | 447,980 | -9.7% | 0.00% | 0.0% |
| Q4 2013 | $2,316,000 | +5.7% | 495,974 | +5.2% | 0.00% | 0.0% |
| Q3 2013 | $2,192,000 | -13.1% | 471,486 | -1.6% | 0.00% | 0.0% |
| Q2 2013 | $2,521,000 | – | 479,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 393,000 | $1,556,000 | 1.48% |
| FORTALEZA ASSET MANAGEMENT INC/ | 98,125 | $389,000 | 0.18% |
| Rhenman & Partners Asset Management AB | 121,537 | $481,000 | 0.14% |
| Baker Brothers Advisors | 1,826,358 | $7,232,000 | 0.09% |
| Rotella Capital Management, Inc. | 21,600 | $86,000 | 0.07% |
| SSI INVESTMENT MANAGEMENT LLC | 117,640 | $466,000 | 0.04% |
| FEDERATED HERMES, INC. | 2,391,400 | $9,470,000 | 0.03% |
| TFS CAPITAL LLC | 96,659 | $383,000 | 0.03% |
| SMITH ASSET MANAGEMENT GROUP LP | 191,038 | $757,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 28,000 | $111,000 | 0.02% |